-carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vivo evaluation.
D000284:Administration, Oral; D000667:Ampicillin / Q000494:pharmacology; D000818:Animals; D002228:Carbenicillin / Q000627:therapeutic use; D004285:Dogs; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D000882:Haplorhini; D007408:Intestinal Absorption; D051379:Mice; D008815:Mice, Inbred Strains; D010403:Penicillin Resistance; D010406:Penicillins / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*
D010406:Penicillins; D000667:Ampicillin; D002228:Carbenicillin